1. Companies
  2. Molecular Partners
  3. Team

  4. Team

Molecular Partners

Molecular Partners

Develops designed ankyrin repeat protein platform therapies used in ophthalmology, oncology, inflammation, and other therapeutic treatments. Learn more
Launch date
Employees
51-200 people
Market cap
€162m
Enterprise valuation
(€4m) (Public information from Sep 2024)
Company register number CH-020.3.028.228-2
Zurich Canton of Zürich (HQ)
http://molecularpartners.com
https://twitter.com/molecularprtnrshttps://www.linkedin.com/company/molecular-partners-ag-zurich-switzerland
Authorizing premium user...